Onychomycosis on HIV-positive patients. Clínica Universitaria Bolivariana 2000 - 2007

Main Article Content

Samuel David González Macías
Ricardo Campuzano Sierra

Abstract

Introduction: Some studies have been conducted on the clinical and epidemiological characteristics of onychomycosis in HIV positive patients, these articles have shown a relationship with the immunocompromised state, the morbidity, and the higher prevalence.


Objetive: To describe the prevalence, clinical and epidemiological characteristics of onychomycosis in a group of HIV positive patients.


Methods:. An observational retrospective study was performed using the hospital database and supported by the written clinical records on 440 HIV positive patients included in the Sexually Transmitted Diseases Program of the Clinica Universitaria Bolivariana.


Results: 63 HIV positive patients had a diagnosis of onychomycosis (14.3%); 56 of which (88.9%) were male. The mean age was 36.9 ± 7.3 years. The average CD4 count was 190 ± 170.8 cells/μL, 50 (79.3%) patients had toenail involvement; 15 (23.8%) patients had a diagnosis of tinea pedis. The most prevalent clinical presentation was white superficial onychomycosis (25.4%), although a big percentage of patients lack this data (42.8%). In 16 patients with mycological exam, most frequent fungi were: Trichophyton rubrum, Trichophyton mentagrophytes and Candida spp (50%, 12.5% and 12.5% respectively).


Conclusion: onychomycosis is a frequent disease in HIV positive patients, and an integral clinical and immunologic diagnosis of those patients should be performed.

Keywords:
onychomycosis, immunosupresion, HIV

Article Details

Author Biographies

Samuel David González Macías, Pontifical Bolivarian University

Bachelor students. Faculty of Medicine, Universidad Pontificia Bolivariana.

Ricardo Campuzano Sierra, Pontifical Bolivarian University

Bachelor students. Faculty of Medicine, Universidad Pontificia Bolivariana.

References

Bastos AC, González N, Montes de Oca I. Síndrome de inmunodeficiencia adquirida frecuencia y etiología de manifestaciones dermatológicas. Rev Med Interna (Caracas) 2002;18:49-72

Cancela García R. Manifestaciones cutáneas del SIDA. Rev Fac Med UNAM 2003;46:162-5

Vander Straten M, Hossain MA, Ghannoum M A. Cutaneus infection, dermatophytosis, onychomycosis, and tinea versicolor. Infect Dis Clin N Am 2003;17:87- 112

Balleste R, Mousqués N, Gezuele E. Onicomicosis. Revisión del tema. Rev Med Uruguay 2003;19:93- 106

Elewski BE. Onychomycosis: Pathogenesis, Diagnosis, and Management. Clin Microbiol Rev 1998;11:415– 29

Rugeles MJ, Vásquez JL, Jaramillo E, Orozco B, Estrada S, Ospina S. Etiología y características clínicas de la onicomicosis en un grupo de pacientes inmunosuprimidos. Infectio 2001;5:7-13

Gupta AK, Ricci MJ. Diagnosing Onychomycosis. Dermatol Clin 2006; 24:365–9

Effendy I, Lecha M, Feuilhade, de Chauvin M, Di Chiacchio N, Baran R. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):S8-12.

Sigurgirsson B, Steigrímsson Ó. Risk factors associated with onychomycosis. JEDAV 2004;18,48-51.

Tosti A, Hay R, Arenas-Guzmán R. Patients at risk: onychomycosis-risk factors identification and active prevention. JEADV 2005;19(Suppl. 1),S13-6.

Surjushe A, Kamath R, Oberai Ch, Saple D, Thakre M, Dharmshale S, et al. A clinical and mycological study of onychomycosis in HIV infection. Indian J Dermatol Venereol Leprol. 2007;73:397-401

Gupta AK, Taborda P, Taborda V, Gilmour J, Rachlis A, Salit I, et al. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol 2000; 39:746-53.

Herranz P, García J, De Lucas R, Gonzalez J, Pena JM, Díaz R, et al. Toenail onychomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine. Br J Dermatol 1997;137:577-80

Piraccini BM, Tosti A. White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch Dermatol. 2004; 140:696-701

Cribier B, Mena ML, Rey D, Partisani M, Fabien V, Lang JM, et al. Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study. Arch Dermatol. 1998; 134:1216-20

Escobar ML, Carmona J. Onicomicosis por hongos ambientales no dermatofíticos. Rev Iberoam Micol 2003;20:6-10.

Escobar V, Carmona-Fonseca J. Examen directo y cultivo en onicomicosis. Piel 2001;16:63-8.

Maurer T, et al. The Effect of Highly Active Antiretroviral Therapy on Dermatologic Disease in a Longitudinal Study of HIV Type 1–Infected Women CID 2004:38,579- 84